Connect with us
Mon – Sat 09:00 – 06:00
Call Us 82838 57755
Metformin Hydrochloride Prolonged and Glimepiride Tablets IP
PRODUCT NAME : GLIFAB-M2
Dosage Form: Tablet
Packing: 10×10 Blister
GLIFAB-M2 Tablet is a combination of anti-diabetic medicines used to manage type 2 diabetes mellitus in adults. It contains Glimepiride 2 mg and Metformin 500 mg (Sustained Release), which work together to control blood sugar levels. Glimepiride increases insulin release, while Metformin reduces glucose production in the liver, helping maintain better glycemic control.
- Real Time 0 Visitors Right Now
MORE DETAILS ABOUT GLIFAB-M2
Glimepiride 1mg/2mg + Metformin HCl 500mg
Glimepiride :
- Has dual molecules of action, by stimulating insulin production and increases activity of peripheral insulin intramuscular receptor
An diabetic that :
- Causes a progressive decrease of fasting blood glucose
Metformin HCl
Displays contra pancreatic effects
Decreases hepatic glucose production
Type II diabetes
Diet and exercise uncontrolled diabetes
Also Available
GLIFAB-MP1 / MP2
Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg
VYOFAB MP1/MP2
Metformin Hydrochloride 500 mg , Prolonged Release and Glimepiride 1 mg, Voglibose 0.1/ 0.2 mg Tablets
AMLOFAB-50 AT / 50
Amlodipine Besylate IP 5 mg + Atenolol 50mg/
GLIFAB-MP1 / MP2
Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg
VYOFAB-0.2/0.3
Voglibose 0.2/0.3
TELFAB-40
Telmisartan 40mg
Indications
- Improvement of postprandial hyperglycemia In diabetes mellitus when sufficient effect has not been obtained
- The combination provides additional glycemic control
Always Trust the Superior BIOMORPH Lifesciences Pvt. Ltd.
